维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Sheremata WA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A controlled trial of natalizumab for relapsing multiple sclerosis 显示文摘	MILLER DH KHAN OA SHEREMATA WA	2003	N Engl J Med2003，348，1：	1
2	A contral trail of natalizumab for relapsing multiple sclerosis显示文摘	Miller DH Khan OA Sheremata WA		0，，：	1
3	A controlled trial of natalizumab for relapsing multiple sclerosis显示文摘	Miller DH Khan OA Sheremata WA	2003	N Engl J Med2003，348，1：	1
4	A safety and pharmacokinetic study of intravenous natalizumab in patients with MS显示文摘	Sheremata WA Vollmer TL Stone LA	1999	Neurology1999，52，5：	1
5	A controlled trial of natalizumab for relapsing multiple sclerosis显示文摘	Miller DH Khan OA Sheremata WA	2003	N Engl J Med2003，348，1：	1
6	The role of CD4 + T-cells in the development of MS显示文摘	Delgado S Sheremata WA	2006	Neurol Res2006，28，3：	1
7	Relationship of the au- tispastieity effect of tizanidine to plasma concentration in patients with multiple sclerosis 显示文摘	Nance PW Sheremata WA Lynch SG	1997	Arch Neurol1997，54，6：	1
8	Centrifugal and centripetal forces in radical new product development under time pressure 显示文摘	Sheremata WA	2000	Academy of Management Review2000，25，：	1
9	Event-related potential P300 in multiple sclerosis: relation to magnetic resonance imaging and cognitive impairment显示文摘	Honig LS Ramsay RE Sheremata WA	1992	Arch Neurol1992，49，：	1
10	Centrifugal and centripetal forces in radical new product development under time pressure显示文摘	SHEREMATA WA	2000	A- cademy of Management Review2000，25，2：	1
11	A controlled trial of natalizumab for relapsing multiple sclerosis显示文摘	Miller DH Khan OA Sheremata WA 	2003	N Engl J Med2003，348，1：	1
12	Guillain-Barr6 syndrome com- plicating acute hepatitis B:A case with detailed electrophysiologi- eal and immunological studies 显示文摘	Berger JR Ayyar R Sheremata WA	1981	Arch Neurol1981，38，6：	1
13	Transient movement disorders and multiple sclerosis显示文摘	Minagar T Sheremata WA Weiner WJ	2002	Parkinsonism Relat Disord2002，9，：	1
14	A controlled trial of natalizumab for relapsing multiple sclerosis 显示文摘	Miller DH Khan OA Sheremata WA	2003	N Engl J Med2003，348，1：	1
15	A controlled trial of natalizumab for relapsing multiple sclerosis显示文摘	MILLER DH KHAN OA SHEREMATA WA	2003	N Engl J Med2003，348，1：	1
16	A controlled trial of natalizumab for relapsing multiple sclerosis 显示文摘	MILLER DH KHAN OA SHEREMATA WA	2003	N Engl J Med2003，348，1：	1
17	Glossopharyngeal neuralgia and MS显示文摘	Minagar A Sheremata WA	2000	Neurology2000，54，6：	1
18	A safety and pharmacokinetic study of intravenous natalizumab in patients with MS 显示文摘	SHEREMATA WA VOLLMER TL STONE LA	1999	Neurology1999，52，5：	1
19	A controlled trial of natalizumab for relapsing multiple sclerosis显示文摘	Miller DH Khan OA Sheremata WA	2003	New Eng J Med2003，348，：	1
20	Interferon-betala reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis显示文摘	Sheremata WA Jy W Delgado S	2006	J Neuroinflammation2006，3，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示